Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 6/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | CYCS | P99999 | 4/20 | 0.35 |
| ▸ | TOP1 | P11387 | 3/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12048587 | 0.88 | TERT (0.43) | TERTABCG2CYCSTOP1 | |
| SCHEMBL29397238 | 0.83 | TERT (0.40) | TERTABCG2CYCSTOP1 | |
| SCHEMBL28702500 | 0.83 | TERT (0.40) | TERTABCG2CYCSTOP1 | |
| SCHEMBL6002479 | 0.83 | TERT (0.38) | TERTABCG2CYCSTOP1ENPP2 | |
| SCHEMBL6711729 | 0.81 | STAT3 (0.49) | TERTABCG2CYCSMAOADYRK1A | |
| SCHEMBL28693190 | 0.77 | TERT (0.43) | TERTABCG2CYCSTOP1ENPP2 | |
| SCHEMBL6000610 | 0.76 | STAT3 (0.43) | TERTABCG2TOP1 | |
| SCHEMBL17687648 | 0.74 | TERT (0.43) | TERTABCG2DYRK1A | |
| SCHEMBL498495 | 0.73 | TERT (0.51) | TERTABCG2CYCSTOP1ENPP2 | |
| SCHEMBL29408468 | 0.73 | TERT (0.51) | TERTABCG2CYCSTOP1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363916-A4 | EMISSIVE MULTICHROMOPHORIC SYSTEMS | UNIV PENNSYLVANIA (US) | 2006-06-28 | — | — | EP | disclosed |
| US-20040067198-A1 | Emissive multichromophoric systems | THERIEN MICHAEL J (US) | 2004-04-08 | — | — | US | disclosed |
| EP-1363916-A2 | EMISSIVE MULTICHROMOPHORIC SYSTEMS | The Trustees of The University of Pennsylvania (US) | 2003-11-26 | — | — | EP | disclosed |
| WO-2002104072-A2 | EMISSIVE MULTICHROMOPHORIC SYSTEMS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2002-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067198-A1 | Emissive multichromophoric systems | MC3R, EML4, TYR | TERT 1534/4885ABCG2 3223/4885CYCS 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.